These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28871481)

  • 1. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?
    Siddique S; Risse J; Canaud G; Zuily S
    Curr Rheumatol Rep; 2017 Sep; 19(10):64. PubMed ID: 28871481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC Pathway Activation and Effect of Sirolimus on Native Kidney Antiphospholipid Syndrome Nephropathy: A Case Report.
    Dufour I; Venot Q; Aydin S; Demoulin N; Canaud G; Morelle J
    Am J Kidney Dis; 2020 Aug; 76(2):288-291. PubMed ID: 31810732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome.
    Knight JS; Kanthi Y
    Semin Immunopathol; 2022 May; 44(3):347-362. PubMed ID: 35122116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the mTORC pathway in the antiphospholipid syndrome.
    Canaud G; Bienaimé F; Tabarin F; Bataillon G; Seilhean D; Noël LH; Dragon-Durey MA; Snanoudj R; Friedlander G; Halbwachs-Mecarelli L; Legendre C; Terzi F
    N Engl J Med; 2014 Jul; 371(4):303-12. PubMed ID: 25054716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiphospholipid syndrome.
    Wautrecht JC
    Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.
    Zhang J; Li C; Han X; Chen Z; Adhikari BK; Wang Y; Wang Y; Sun J
    Ann Med; 2021 Dec; 53(1):1328-1339. PubMed ID: 34409894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiphospholipid syndrome - often overlooked cause of vascular occlusions?
    Svenungsson E; Antovic A
    J Intern Med; 2020 Apr; 287(4):349-372. PubMed ID: 31957081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease.
    Harifi G; Nour-Eldine W; Noureldine MHA; Berjaoui MB; Kallas R; Khoury R; Uthman I; Al-Saleh J; Khamashta MA
    Autoimmun Rev; 2018 Mar; 17(3):256-266. PubMed ID: 29339317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of antiphospholipid syndrome.
    Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Menegatti E; Roccatello D; Sciascia S
    Clin Immunol; 2020 Dec; 221():108597. PubMed ID: 32961331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is antiphospholipid syndrome?
    Erkan D; Lockshin MD
    Curr Rheumatol Rep; 2004 Dec; 6(6):451-7. PubMed ID: 15527704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?
    Saponjski J; Stojanovich L; Djokovic A; Petkovic M; Mrda D
    Autoimmun Rev; 2011 Feb; 10(4):235-7. PubMed ID: 21095242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis in antiphospholipid syndrome.
    Lally L; Sammaritano LR
    Rheum Dis Clin North Am; 2015; 41(1):109-23, ix. PubMed ID: 25399943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current topics in vascular disorders].
    Ichikawa K; Koike T
    Nihon Rinsho; 1994 Aug; 52(8):2152-7. PubMed ID: 7933603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome.
    Álvarez D; Morales-Prieto DM; Cadavid ÁP
    Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.